Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV

Background:Cross-sectional studies suggest an association between bacterial vaginosis (BV) and HIV-1 infection. However, an assessment of a temporal effect was not possible. Objectives:To determine the association of BV and other disturbances of vaginal flora with HIV seroconversion among pregnant and postnatal women in Malawi, Africa. Design:Longitudinal follow-up of pregnant and postpartum women. Methods:Women attending their first antenatal care visit were screened for HIV after counselling and obtaining informed consent. HIV-seronegative women were enrolled and followed during pregnancy and after delivery. These women were again tested for HIV at delivery and at 6-monthly visits postnatally. Clinical examinations and collection of laboratory specimens (for BV and sexually transmitted diseases) were conducted at screening and at the postnatal 6-monthly visits. The diagnosis of BV was based on clinical criteria. Associations of BV and other risk factors with HIV seroconversion, were examined using contingency tables and multiple logistic regression analyses on antenatal data, and Kaplan–Meier proportional hazards analyses on postnatal data. Results:Among 1196 HIV-seronegative women who were followed antenatally for a median of 3.4 months, 27 women seroconverted by time of delivery. Postnatally, 97 seroconversions occurred among 1169 seronegative women who were followed for a median of 2.5 years. Bacterial vaginosis was significantly associated with antenatal HIV seroconversion (adjusted odds ratio = 3.7) and postnatal HIV seroconversion (adjusted rate ratio = 2.3). There was a significant trend of increased risk of HIV seroconversion with increasing severity of vaginal disturbance among both antenatal and postnatal women. The approximate attributable risk of BV alone was 23% for antenatal HIV seroconversions and 14% for postnatal seroconversions. Conclusions:This prospective study suggests that progressively greater disturbances of vaginal flora, increase HIV acquisition during pregnancy and postnatally. The screening and treating of women with BV could restore normal flora and reduce their susceptibility to HIV.

[1]  G. Dallabetta,et al.  TREATING SEXUALLY TRANSMITTED DISEASES TO CONTROL HIV TRANSMISSION , 1997 .

[2]  D. Eschenbach,et al.  The relationship of hydrogen peroxide‐producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women , 1992, Obstetrics and gynecology.

[3]  R. Coombs,et al.  Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission , 1991, The Journal of experimental medicine.

[4]  R. Erkkola,et al.  Should male consorts of women with bacterial vaginosis be treated? , 1989, Genitourinary medicine.

[5]  P. Mårdh.  The vaginal ecosystem. , 1991, American journal of obstetrics and gynecology.

[6]  R. Anderson,et al.  Simplified gram stain interpretive method for diagnosis of bacterial vaginosis. , 1992, American journal of obstetrics and gynecology.

[7]  J. Hauth,et al.  Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis , 1995, The New England journal of medicine.

[8]  K. Holmes,et al.  Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis , 1989, Journal of clinical microbiology.

[9]  Heterosexual transmission of HIV. , 1992, JAMA.

[10]  J. Canner,et al.  Preparations for AIDS vaccine evaluations. Rate of new HIV infection in a cohort of women of childbearing age in Malawi. , 1994, AIDS research and human retroviruses.

[11]  K. Holmes,et al.  Vaginal redox potential in bacterial vaginosis (nonspecific vaginitis). , 1985, The Journal of infectious diseases.

[12]  J. Kreiss,et al.  Shedding of HIV-1 in the genital tract. , 1996, AIDS.

[13]  J. Canner,et al.  Reported condom use is not associated with incidence of sexually transmitted diseases in Malawi , 1996, AIDS.

[14]  S. Hillier.  Diagnostic microbiology of bacterial vaginosis. , 1993, American journal of obstetrics and gynecology.

[15]  T. Quinn.  Association of sexually transmitted diseases and infection with the human immunodeficiency virus: Biological cofactors and markers of behavioural interventions , 1996, International journal of STD & AIDS.

[16]  P. Vernazza,et al.  Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 , 1997, The Lancet.

[17]  M. Krohn,et al.  Characteristics of three vaginal flora patterns assessed Gram stain among pregnant women , 1992 .

[18]  D. Hoover,et al.  Trends of HIV‐1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi , 1998, AIDS.

[19]  J. Paavonen.  Physiology and ecology of the vagina. , 1983, Scandinavian journal of infectious diseases. Supplementum.

[20]  Q. Karim.  Global Strategies for the Prevention of HIV Transmission from Mothers to Infants , 2000, Annals of the New York Academy of Sciences.

[21]  K. Holmes,et al.  Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid , 1983, Journal of clinical microbiology.

[22]  P. Moodley,et al.  Bacterial vaginosis and associated infections in pregnancy , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[23]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[24]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[25]  K. Nelson,et al.  Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand , 1995, AIDS.

[26]  N. Sewankambo,et al.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis , 1997, The Lancet.

[27]  K. Holmes,et al.  Diagnosis and clinical manifestations of bacterial vaginosis. , 1988, American journal of obstetrics and gynecology.

[28]  D. Anderson,et al.  Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. , 1992, American journal of obstetrics and gynecology.

[29]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.

[30]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[31]  K. Tomecki.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial: Grosskurth J, Mosha F, Todd J, et al. Lancet 1995;346:530–536 , 1996 .

[32]  J. Wasserheit,et al.  Epidemiological Synergy: Interrelationships between Human Immunodeficiency Virus Infection and Other Sexually Transmitted Diseases , 1992, Sexually transmitted diseases.

[33]  J. McFee,et al.  Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. , 1995, American journal of obstetrics and gynecology.

[34]  D R Hoover,et al.  Extension of the life table to repeating and changing events. , 1996, American journal of epidemiology.

[35]  M. Vejtorp,et al.  Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner , 1988, British journal of obstetrics and gynaecology.